MPE and ALAN webinar | Patient and clinician involvement in the EU HTA regulation

  Рет қаралды 424

Myeloma Patients Europe

Myeloma Patients Europe

Ай бұрын

Recording of the webinar held on 26 June 2024 on patient and clinician involvement in the EU HTA regulation. The webinar was organised by Myeloma Patients Europe (MPE) and Acute Leukemia Advocates Network (ALAN) and counted with the participation of the following speakers:
• Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)
• François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)
• Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia
• Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)

Пікірлер
MPE/ALAN Webinar | EU HTA
55:55
Myeloma Patients Europe
Рет қаралды 437
MPE Masterclass 2024  | Cross border medicine and trials access
1:21
Myeloma Patients Europe
Рет қаралды 199
Как бесплатно замутить iphone 15 pro max
00:59
ЖЕЛЕЗНЫЙ КОРОЛЬ
Рет қаралды 6 МЛН
Day three of MPE´s coverage at EHA 2024
1:57
Myeloma Patients Europe
Рет қаралды 55
How To Price For B2B | Startup School
17:46
Y Combinator
Рет қаралды 24 М.
EHA 2024 | DREAMM 7 study
2:12
Myeloma Patients Europe
Рет қаралды 133
Day one of MPE´s coverage at EHA 2024
1:06
Myeloma Patients Europe
Рет қаралды 80
Masterclass 2024 | EU Health Technology Assessment Regulation
3:03
Myeloma Patients Europe
Рет қаралды 55
EHA2024 |The IMROZ study
3:37
Myeloma Patients Europe
Рет қаралды 155
EHA 2024 | The DREAMM-8 study
4:36
Myeloma Patients Europe
Рет қаралды 173